It can be difficult because symptoms such as fatigue, constipation, and changes in appetite can occur with both
and ensure patients receive information about risks and side effects
1988 GHK-Cu Structure CAS #: 49557-75-7 Molecular Formula: CHCuNO Molecular Weight: 340.9 g/mol PubChem ID: 5311476 BPC-157 Structure CAS #: 137525-51-0 Molecular Formula: CHCuNO Molecular Weight: 340.9 g/mol PubChem ID: 5311476 TB-500 Structure CAS #: 77591-33-4 Molecular Formula: CHNOS Molecular Weight: 4963.5 g/mol PubChem ID: 16132321 KPV Structure CAS #: 3061-91-6 Formula: CHNO Molecular Weight: 388.4 g/mol PubChem ID: 16129619 Research Findings The KLOW Blend, which combines GHK-Cu, BPC-157, TB-500, and KPV, has been studied in structural, vascular, dermatological, and systemic models
When tissues sustain damage, GHK-Cu is released from extracellular matrix proteins including SPARC and collagen, functioning as a matrikine, a signal molecule that activates repair mechanisms